Oneview Healthcare PLC Chess Depository Interests repr 1 (AU:ONE)
ASX:ONE
ONE Stock Chart & Stats
AU$0.26
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.26
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.17 - AU$0.41
Previous CloseN/A
Volume4.96K
Average Volume (3M)344.03K
Market Cap
AU$141.94M
Enterprise ValueAU$82.17M
Total Cash (Recent Filing)AU$4.60M
Total Debt (Recent Filing)AU$1.99M
Price to Earnings (P/E)―
Beta1.38
Next Earnings
Sep 01, 2026EPS Estimate
>-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding830,387,760
10 Day Avg. Volume303,620
30 Day Avg. Volume344,030
Financial Highlights & Ratios
PEG Ratio0.76
Price to Book (P/B)47.09
Price to Sales (P/S)14.39
P/FCF Ratio-20.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.45Price Target Upside73.08% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.01
Revenue Forecast (FY)AU$15.75M
Bulls Say, Bears Say
Bulls Say
Consistent Revenue Growth & Deployment MomentumSustained top-line growth and accelerating deployments indicate product-market fit and expanding recurring revenue. A larger installed base (endpoints target +20% in 2026) supports future ARR, improves unit economics as fixed costs scale, and creates a more stable revenue foundation over the medium term.
Baxter Partnership & GPO Market AccessGPO inclusion materially broadens U.S. commercial reach and shortens procurement friction with major health systems. Structurally, this expands the addressable market and provides a repeatable channel for enterprise sales, improving long-term go-to-market efficiency if conversion executes.
AI-driven Engineering Productivity GainsMeasurable SDLC productivity gains lower development costs and accelerate feature delivery, enabling faster deployments and potentially higher gross margins over time. Operationalizing AI across engineering is a durable structural lever to improve time-to-market and reduce incremental R&D expense.
Bears Say
Persistent Negative Cash Flow And Operating LossesOngoing cash burn and repeated operating losses force reliance on external financing, creating dilution and limiting strategic optionality. Without sustained margin expansion or materially higher recurring revenue, the company faces balance sheet pressure that can constrain growth investments over the next several quarters.
Long Sales Cycles And Pipeline Conversion TimingExtended procurement timelines delay revenue recognition and make forecasting and cash planning difficult. Reliance on large, slow enterprise deals increases execution risk; if conversion stalls, revenue and margin improvement plans tied to that pipeline may not materialize within the expected 2-6 month horizon.
Growth Reliant On Upsell And Enterprise ExpansionA high share of future upside depends on upselling existing customers and large enterprise conversions. This concentration means revenue growth is sensitive to customer budget cycles, churn, and successful rollouts; failure to convert white space would stall scalable, predictable ARR growth.
Oneview Healthcare Chess Depository Interests repr 1 News
ONE FAQ
What was Oneview Healthcare PLC Chess Depository Interests repr 1’s price range in the past 12 months?
Oneview Healthcare PLC Chess Depository Interests repr 1 lowest share price was AU$0.17 and its highest was AU$0.41 in the past 12 months.
What is Oneview Healthcare PLC Chess Depository Interests repr 1’s market cap?
Oneview Healthcare PLC Chess Depository Interests repr 1’s market cap is AU$141.94M.
When is Oneview Healthcare PLC Chess Depository Interests repr 1’s upcoming earnings report date?
Oneview Healthcare PLC Chess Depository Interests repr 1’s upcoming earnings report date is Sep 01, 2026 which is in 155 days.
How were Oneview Healthcare PLC Chess Depository Interests repr 1’s earnings last quarter?
Oneview Healthcare PLC Chess Depository Interests repr 1 released its earnings results on Feb 11, 2026. The company reported -AU$0.01 earnings per share for the quarter, beating the consensus estimate of -AU$0.012 by AU$0.002.
Is Oneview Healthcare PLC Chess Depository Interests repr 1 overvalued?
According to Wall Street analysts Oneview Healthcare PLC Chess Depository Interests repr 1’s price is currently Undervalued.
Does Oneview Healthcare PLC Chess Depository Interests repr 1 pay dividends?
Oneview Healthcare PLC Chess Depository Interests repr 1 does not currently pay dividends.
What is Oneview Healthcare PLC Chess Depository Interests repr 1’s EPS estimate?
Oneview Healthcare PLC Chess Depository Interests repr 1’s EPS estimate is >-0.01.
How many shares outstanding does Oneview Healthcare PLC Chess Depository Interests repr 1 have?
Oneview Healthcare PLC Chess Depository Interests repr 1 has 830,387,760 shares outstanding.
What happened to Oneview Healthcare PLC Chess Depository Interests repr 1’s price movement after its last earnings report?
Oneview Healthcare PLC Chess Depository Interests repr 1 reported an EPS of -AU$0.01 in its last earnings report, beating expectations of -AU$0.012. Following the earnings report the stock price went down -7.692%.
Which hedge fund is a major shareholder of Oneview Healthcare PLC Chess Depository Interests repr 1?
Currently, no hedge funds are holding shares in AU:ONE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Oneview Healthcare Chess Depository Interests repr 1 Stock Smart Score
Company Description
Oneview Healthcare PLC Chess Depository Interests repr 1
Oneview Healthcare Chess Depository Interests repr 1 (ONE) is a healthcare technology company that focuses on providing innovative digital solutions to enhance patient and operational outcomes in the healthcare sector. The company primarily offers a digital patient engagement platform that streamlines communication between healthcare providers and patients, facilitates data sharing, and improves overall patient experience. Oneview Healthcare operates within the broader healthcare technology industry, catering to hospitals, clinics, and other healthcare organizations seeking to modernize their patient care processes.
Oneview Healthcare Chess Depository Interests repr 1 (ONE) Earnings & Revenues
ONE Company Deck
ONE Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call communicates strong commercial momentum and meaningful progress on product innovation and AI‑driven productivity—highlighted by 21% reported revenue growth (25%+ constant currency), accelerated deployments, a major Baxter partnership and clear cost‑efficiency gains (H2 OpEx down and >EUR 1.4m annualized run‑rate savings). However, material challenges remain: the company is still operating at an EBITDA loss (EUR 8.1m), cash is modest (EUR 4.6m), gross margin was compressed by revenue mix and conversion of a large Baxter/GPO pipeline and enterprise expansions are uncertain and subject to lengthy sales cycles and regulatory/capital‑spending risks. On balance, the positives (growth, partnerships, product/AI progress and OpEx improvement) outweigh the negatives, but execution and pipeline conversion will be critical to sustain the trajectory.View all AU:ONE earnings summariesONE Stock 12 Month Forecast
Average Price Target
AU$0.45
▲(73.08% Upside)
Technical Analysis
Cogstate Ltd
―
Mach7 Technologies
―
Beamtree Holdings Ltd
―
Alcidion Group Limited
―
PainChek Ltd
―
Options Prices
Currently, No data available
---